drugset / Trial / NCT06418711
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Timeline
- Start
- 2024-09-11
- Primary completion
- 2025-11-10
- Completion
- 2025-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clofazimine | Small molecule | 80 mg | Inhaled |